(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | --371.17M | 57.87%813.02M | 50.78%488.11M | 11.97%514.99M | --323.72M | 32.48%459.94M | --347.17M |
Operating income | 371.17M | 57.87%813.02M | 50.78%488.11M | 11.97%514.99M | 323.72M | 32.48%459.94M | 347.17M |
Cost of sales | ---208.81M | -55.52%-487.6M | -39.64%-287.57M | -1.87%-313.53M | ---205.95M | -30.74%-307.77M | ---235.41M |
Operating expenses | -208.81M | -55.52%-487.6M | -39.64%-287.57M | -1.87%-313.53M | -205.95M | -30.74%-307.77M | -235.41M |
Gross profit | 162.37M | 61.52%325.42M | 70.28%200.54M | 32.40%201.47M | 117.77M | 36.14%152.16M | 111.77M |
Selling expenses | ---7.75M | -42.74%-10.35M | -7.28%-6.35M | -129.25%-7.25M | ---5.92M | -127.97%-3.16M | ---1.39M |
Administrative expenses | ---33.82M | -85.79%-58.5M | -150.41%-44.62M | -28.24%-31.49M | ---17.82M | -78.08%-24.55M | ---13.79M |
Research and development expenses | ---64.35M | -54.41%-98.8M | -146.32%-75.63M | -76.21%-63.98M | ---30.71M | -164.65%-36.31M | ---13.72M |
Impairment and provision | ---11.67M | -30.11%-55.38M | 65.17%-11.74M | -143.99%-42.56M | ---33.71M | -127.02%-17.44M | ---7.68M |
-Other impairment is provision | ---11.67M | -30.11%-55.38M | 65.17%-11.74M | -143.99%-42.56M | ---33.71M | -127.02%-17.44M | ---7.68M |
Special items of operating profit | --5.73M | 147.28%27.2M | 150.63%23.5M | 39.38%11M | --9.38M | 4,284.44%7.89M | --180K |
Operating profit | 50.52M | 92.89%129.6M | 119.75%85.69M | -14.51%67.19M | 39M | 4.27%78.59M | 75.37M |
Financing cost | ---7.76M | -29.47%-11.7M | -25.07%-8.29M | -10.40%-9.03M | ---6.63M | -25.16%-8.18M | ---6.54M |
Share of profits of associates | ---15K | -115.27%-20K | ---- | 695.45%131K | ---21K | 67.65%-22K | ---68K |
Special items of earning before tax | ---635.11M | 1.70%-146.63M | -369.34%-140.33M | -474.82%-149.17M | ---29.9M | -4.15%-25.95M | ---24.92M |
Earning before tax | -592.37M | 68.36%-28.76M | -2,669.54%-62.93M | -304.55%-90.88M | 2.45M | 1.34%44.43M | 43.85M |
Tax | --2.59M | -108.79%-446K | 131.90%1.5M | 163.04%5.07M | ---4.69M | 10.15%-8.05M | ---8.96M |
After-tax profit from continuing operations | -589.77M | 65.97%-29.2M | -2,641.28%-61.43M | -335.85%-85.81M | -2.24M | 4.29%36.38M | 34.89M |
Earning after tax | -589.77M | 65.97%-29.2M | -2,641.28%-61.43M | -335.85%-85.81M | -2.24M | 4.29%36.38M | 34.89M |
Minority profit | --3.13M | 238.76%4.55M | 390.76%2.39M | 363.01%1.34M | --487K | -83.15%-511K | ---279K |
Profit attributable to shareholders | -592.91M | 61.27%-33.75M | -2,239.52%-63.82M | -336.22%-87.16M | -2.73M | 4.91%36.9M | 35.17M |
Basic earnings per share | -19.09 | 66.07%-1.13 | -1,881.82%-2.18 | -306.83%-3.33 | -0.11 | -20.69%1.61 | 2.03 |
Diluted earnings per share | -19.09 | 66.07%-1.13 | -1,881.82%-2.18 | -306.83%-3.33 | -0.11 | -20.69%1.61 | 2.03 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data